PT  - JOURNAL ARTICLE
AU  - Suraj Pathak
AU  - Scott Cherry
AU  - Samreen Samad
AU  - Ambreen Aftab
TI  - Successful clozapine rechallenge in a patient with suspected drug induced lupus
AID  - 10.1136/bcr-2018-228574
DP  - 2019 Apr 01
TA  - BMJ Case Reports
PG  - e228574
VI  - 12
IP  - 4
4099  - http://casereports.bmj.com/content/12/4/e228574.short
4100  - http://casereports.bmj.com/content/12/4/e228574.full
SO  - BMJ Case Reports2019 Apr 01; 12
AB  - Clozapine is the most effective treatment for patients with refractory schizophrenia. Clozapine is also associated with serious and potentially lethal side effects including drug induced lupus (DIL). There have been four previous published case reports describing clozapine inducing a lupus-like syndrome including one previous case where a clozapine rechallenge was attempted without success. This case report describes a successful clozapine rechallenge in a patient with suspected DIL.